Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-28

Clinical Trial Update: LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating LDGraft in a single-level anterior lumbar interbody fusion for degenerative lumbar spine conditions; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LDGraft

Snippet

Sponsor: Locate Bio Pty Ltd | Conditions: Degenerative Disc Disease, Lumbar Disc Disease | Phase 1, Phase 2 | Status: RECRUITING